{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:23:51Z","timestamp":1793723031055,"version":"4.6.1"},"reference-count":29,"publisher":"MyJove Corporation","issue":"222","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68753","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T23:01:13Z","timestamp":1754521273000},"source":"Crossref","is-referenced-by-count":2,"title":["Development of Mouse-Derived Organoid Lines from Fallopian Tube Epithelial Cells for High Grade Serous Ovarian Carcinoma Modeling"],"prefix":"10.3791","author":[{"given":"Elaine M.","family":"Hern\u00e1ndez Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Jose","family":"Pundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","type":"journal-article","article-title":"DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination","volume":"127","author":"Korch","year":"2012","unstructured":"Korch, C. et al. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol. Oncol. 127 (1), 241-248 (2012).","journal-title":"Gynecol. Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","type":"journal-article","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","unstructured":"Domcke, S., Sinha, R., Levine, D. A., Sander, C., Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun. 4, 2126 (2013).","journal-title":"Nat Commun"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","type":"journal-article","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Anglesio","year":"2013","unstructured":"Anglesio, M. S. et al. Type-specific cell line models for type-specific ovarian cancer research. PLoS One. 8 (9), e72162 (2013).","journal-title":"PLoS One"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"e103988","DOI":"10.1371\/journal.pone.0103988","type":"journal-article","article-title":"Ovarian cancer cell line panel (OCCP): Clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","unstructured":"Beaufort, C. M. et al. Ovarian cancer cell line panel (OCCP): Clinical importance of in vitro morphological subtypes. PLoS One. 9 (9), e103988 (2014).","journal-title":"PLoS One"},{"issue":"20","key":"ref5","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","type":"journal-article","article-title":"CRISPR\/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma","volume":"76","author":"Walton","year":"2016","unstructured":"Walton, J. et al. CRISPR\/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma. Cancer Res. 76 (20), 6118-6129 (2016).","journal-title":"Cancer Res"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","type":"journal-article","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8 (1), 1093 (2017).","journal-title":"Nat. Commun"},{"issue":"7353","key":"ref7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","type":"journal-article","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 474 (7353), 609-615 (2011).","journal-title":"Nature"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","type":"journal-article","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","unstructured":"Kim, J., Coffey, D. M., Creighton, C. J., Yu, Z., Hawkins, S. M., Matzuk, M. M. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci U S A. 109 (10), 3921-3926 (2012).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","type":"journal-article","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Sherman-Baust","year":"2014","unstructured":"Sherman-Baust, C. A. et al. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. J Pathol. 233 (3), 228-237 (2014).","journal-title":"J Pathol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","type":"journal-article","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","unstructured":"Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell. 24 (6), 751-765 (2013).","journal-title":"Cancer Cell"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/embo-reports\/kve064","type":"journal-article","article-title":"A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent","volume":"2","author":"Vooijs","year":"2001","unstructured":"Vooijs, M., Berns, J. A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2 (4), 293-297 (2001).","journal-title":"EMBO Rep"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/nar\/gkl1108","type":"journal-article","article-title":"Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC\/PAC recombineering techniques","volume":"35","author":"Semprini","year":"2007","unstructured":"Semprini, S. et al. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC\/PAC recombineering techniques. Nucleic Acids Res. 35 (5), 1402-1410 (2007).","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"ref13","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.161269798","type":"journal-article","article-title":"Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells","volume":"98","author":"Loonstra","year":"2001","unstructured":"Loonstra, A. et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A. 98 (16) 9209-9214 (2001).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-20-0455","type":"journal-article","article-title":"Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer","volume":"11","author":"Zhang","year":"2021","unstructured":"Zhang, S. et al. Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer. Cancer Discov. 11 (2), 362-383 (2021).","journal-title":"Cancer Discov"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/2159-8290.CD-20-0818","type":"journal-article","article-title":"Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy","volume":"11","author":"Yver","year":"2021","unstructured":"Yver, S. et al. Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. Cancer Discov. 11 (2), 384-407 (2021).","journal-title":"Cancer Discov"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","type":"journal-article","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","unstructured":"L\u00f5hmussaar, K. et al. Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. Nat. Commun. 11 (1), 2660 (2020).","journal-title":"Nat. Commun"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.celrep.2019.12.034","type":"journal-article","article-title":"Mouse ovarian cancer models recapitulate the human tumor microenvironment and patient response to treatment","volume":"30","author":"Maniati","year":"2020","unstructured":"Maniati, E. et al. Mouse ovarian cancer models recapitulate the human tumor microenvironment and patient response to treatment. Cell Reports. 30 (2), 525-540.e7 (2020).","journal-title":"Cell Reports"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"101164","DOI":"10.1016\/j.xpro.2022.101164","type":"journal-article","article-title":"Protocol to generate mouse oviduct epithelial organoids for viral transduction and whole-mount 3D imaging","volume":"3","author":"Ford","year":"2022","unstructured":"Ford, M. J., Harwalkar, K., Yamanaka, Y. Protocol to generate mouse oviduct epithelial organoids for viral transduction and whole-mount 3D imaging. STAR Protoc. 3 (1), 101164 (2022).","journal-title":"STAR Protoc"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.scr.2018.08.021","type":"journal-article","article-title":"Long-term organoid culture reveals enrichment of organoid-forming epithelial cells in the fimbrial portion of mouse fallopian tube","volume":"32","author":"Xie","year":"2018","unstructured":"Xie, Y., Park, E.-S, Xiang, D. Li, Z. Long-term organoid culture reveals enrichment of organoid-forming epithelial cells in the fimbrial portion of mouse fallopian tube. Stem Cell Res. 32, 51-60 (2018).","journal-title":"Stem Cell Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","type":"journal-article","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","unstructured":"Zhao, Z. et al. Organoids. Nat Rev Methods Primers. 2, 94 (2022).","journal-title":"Nat Rev Methods Primers"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1084\/jem.145.1.204","type":"journal-article","article-title":"A murine tumor producing a matrix of basement membrane","volume":"145","author":"Orkin","year":"1977","unstructured":"Orkin, R. W. et al. A murine tumor producing a matrix of basement membrane. J Exp Med. 145 (1), 204-220 (1977).","journal-title":"J Exp Med"},{"key":"ref22","volume-title":"Homology-directed repair using the Alt-R CRISPR-Cas9 System and HDR Donor Oligos","year":"2022","unstructured":"Integrated DNA Technologies (IDT). Homology-directed repair using the Alt-R CRISPR-Cas9 System and HDR Donor Oligos. At <https:\/\/idtsfprod.blob.core.windows.net\/sitefinity\/docs\/default-source\/protocol\/homology-directed-repair-using-the-alt-r-crispr-cas9-system-and-hdr-donor-oligos.pdf?sfvrsn=47121607_6> (2022)."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"104603","DOI":"10.1016\/j.critrevonc.2024.104603","type":"journal-article","article-title":"The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features","volume":"208","author":"Santoro","year":"2025","unstructured":"Santoro, A. et al. The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features. Crit Rev Oncol Hematol. 208, 104603 (2025).","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","type":"journal-article","article-title":"High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","unstructured":"Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z., Telleria, C. High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 20 (4), 952 (2019).","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/cells12060930","type":"journal-article","article-title":"Revolutionizing disease modeling: The emergence of organoids in cellular systems","volume":"12","author":"Silva-Pedrosa","year":"2023","unstructured":"Silva-Pedrosa, R., Salgado, A. J., Ferreira, P. E. Revolutionizing disease modeling: The emergence of organoids in cellular systems. Cells. 12 (6), 930 (2023).","journal-title":"Cells"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mrd.21021","type":"journal-article","article-title":"ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells","volume":"76","author":"Claassen","year":"2009","unstructured":"Claassen, D. A., Desler, M. M., Rizzino, A. ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Mol Reprod Dev. 76 (8), 722-732 (2009).","journal-title":"Mol Reprod Dev"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","type":"journal-article","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","unstructured":"Leibowitz, M. et al. Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing. Nat Genet. 53 (6), 895-905 (2021).","journal-title":"Nat Genet"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","type":"journal-article","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 25 (5), 838-849 (2019).","journal-title":"Nat Med"},{"issue":"1-2","key":"ref29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000479006","type":"journal-article","article-title":"Ovarian cancer: A heterogeneous disease","volume":"85","author":"Kossa\u00ef","year":"2018","unstructured":"Kossa\u00ef, M., Leary, A., Scoazec, J.-Y.,Genestie, C. Ovarian cancer: A heterogeneous disease. Pathobiology. 85 (1-2), 41-49 (2018).","journal-title":"Pathobiology"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68753\/development-mouse-derived-organoid-lines-from-fallopian-tube","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:42:06Z","timestamp":1792593726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68753\/development-mouse-derived-organoid-lines-from-fallopian-tube"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":29,"journal-issue":{"issue":"222","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68753","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}